Sweden’s market for diabetes devices is expected to reach USD 29 billion by the end of 2021. The market is projected to grow at a CAGR of nearly 6% for the duration 2016-2021.
North America is the dominating market in the current scenario, with the USA accounting for more than one-thirds of the global market share. Following North America is Europe. Europe is the second largest market for diabetes devices in the world. This can be attributed to the rapidly aging population in this region. This growth is expected to saturate in the future, primarily due to the developments in the APAC and Latin American regions. These markets are expected to overtake Europe in terms of market share.
This escalation is developing the need to analyze, review and forecast the growth of the diabetes devices market. Owing to the rapid evolution of the market in the use of glucose monitoring device, medical device companies that are able to launch new innovative equipment will be rewarded with huge benefits.
Sweden Diabetes Devices Market-Market Dynamics
The report details several factors driving and restraining the market. Some of these are listed below.
Drivers
Some of the factors contributing to the growth of the market are:
Restraints
Patent expiries, lack of proper reimbursement policies and expensive diagnosis and treatment procedures are the major restraints on the diabetes care devices market.
The report studies in detail the markets for different diabetes care devices, which include glucose monitoring devices (blood glucose meters, lancets, blood glucose testing strips, continuous glucose monitoring devices) and insulin delivery devices (insulin syringes, insulin pumps, insulin pens and injection). Glucose monitoring devices currently dominate the market.
What the Report Offers
Covering 3 categories, 8 segments across 25 countries - offering over 8,600 data points
Looking to Customize Report?
